​

Ocular Therapeutix (OCUL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Ocular Therapeutix Revenue Highlights

Latest Revenue (Y)

$63.46M

Latest Revenue (Q)

$13.39M

Main Segment (Y)

Product revenue, net

Ocular Therapeutix Revenue by Period

Ocular Therapeutix Revenue by Year

DateRevenueChange
2024-12-31$63.46M8.59%
2023-12-31$58.44M13.49%
2022-12-31$51.49M18.32%
2021-12-31$43.52M150.08%
2020-12-31$17.40M311.71%
2019-12-31$4.23M112.41%
2018-12-31$1.99M3.48%
2017-12-31$1.92M1.91%
2016-12-31$1.89M7.83%
2015-12-31$1.75M126.68%
2014-12-31$772.00K100.00%
2013-12-31--100.00%
2012-12-31$10.00K-

Ocular Therapeutix generated $63.46M in revenue during NA 2024, up 8.59% compared to the previous quarter, and up 1501.32% compared to the same period a year ago.

Ocular Therapeutix Revenue by Quarter

DateRevenueChange
2025-06-30$13.39M25.96%
2025-03-31$10.63M-37.75%
2024-12-31$17.08M10.74%
2024-09-30$15.43M-6.18%
2024-06-30$16.44M11.73%
2024-03-31$14.71M-0.59%
2023-12-31$14.80M-0.99%
2023-09-30$14.95M-1.55%
2023-06-30$15.19M13.55%
2023-03-31$13.37M-4.99%
2022-12-31$14.08M17.64%
2022-09-30$11.96M-2.45%
2022-06-30$12.27M-6.98%
2022-03-31$13.19M7.14%
2021-12-31$12.31M1.28%
2021-09-30$12.15M3.71%
2021-06-30$11.72M59.60%
2021-03-31$7.34M-0.10%
2020-12-31$7.35M25.07%
2020-09-30$5.88M274.51%
2020-06-30$1.57M-39.86%
2020-03-31$2.61M15.65%
2019-12-31$2.26M172.14%
2019-09-30$829.00K27.54%
2019-06-30$650.00K32.11%
2019-03-31$492.00K-2.38%
2018-12-31$504.00K1.20%
2018-09-30$498.00K-23.15%
2018-06-30$648.00K90.59%
2018-03-31$340.00K-30.18%
2017-12-31$487.00K-6.88%
2017-09-30$523.00K19.41%
2017-06-30$438.00K-7.79%
2017-03-31$475.00K-7.05%
2016-12-31$511.00K7.13%
2016-09-30$477.00K8.16%
2016-06-30$441.00K-3.71%
2016-03-31$458.00K5.05%
2015-12-31$436.00K1.63%
2015-09-30$429.00K-6.54%
2015-06-30$459.00K7.75%
2015-03-31$426.00K-15.64%
2014-12-31$505.00K253.15%
2014-09-30$143.00K47.42%
2014-06-30$97.00K259.26%
2014-03-31$27.00K100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Ocular Therapeutix generated $13.39M in revenue during Q2 2025, up 25.96% compared to the previous quarter, and up 91.03% compared to the same period a year ago.

Ocular Therapeutix Revenue Breakdown

Ocular Therapeutix Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 18
Product revenue, net$63.46M$57.87M--
Collaboration revenue$262.00K$573.00K$1.04M-
Product--$50.46M$1.99M

Ocular Therapeutix's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product revenue, net (99.59%), and Collaboration revenue (0.41%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 18Sep 18Jun 18Mar 18
Product$13.39M$15.03M$13.21M$13.90M$11.91M$12.14M$12.50M$504.00K$498.00K$648.00K$340.00K------
Collaboration revenue$64.00K$64.00K$125.00K$78.00K$59.00K$125.00K$131.00K$157.00K$160.00K$173.00K$52.00K$122.00K$689.00K----
Product revenue, net-$10.63M$33.40M$15.35M$14.71M$42.92M$14.95M----------

Ocular Therapeutix's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (99.52%), and Collaboration revenue (0.48%).

Ocular Therapeutix Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLPGGalapagos$239.70M$62.43M
OCULOcular Therapeutix$63.46M$13.39M
ABCLAbCellera Biologics$28.83M$4.24M
LQDALiquidia$14.00M$3.12M
CLDXCelldex Therapeutics$7.02M$695.00K
GPCRStructure Therapeutics--
ETNB89bio--
COGTCogent Biosciences--
VRDNViridian Therapeutics--
VERAVera Therapeutics--
CELCCelcuity--

OCUL Revenue FAQ

What is Ocular Therapeutix’s yearly revenue?

Ocular Therapeutix's yearly revenue for 2024 was $63.46M, representing an increase of 8.59% compared to 2023. The company's yearly revenue for 2023 was $58.44M, representing an increase of 13.49% compared to 2022. OCUL's yearly revenue for 2022 was $51.49M, representing an increase of 18.32% compared to 2021.

What is Ocular Therapeutix’s quarterly revenue?

Ocular Therapeutix's quarterly revenue for Q2 2025 was $13.4M, a 25.96% increase from the previous quarter (Q1 2025), and a -18.53% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $10.63M, a -37.75% decrease from the previous quarter (Q4 2024), and a -27.73% decrease year-over-year (Q1 2024). OCUL's quarterly revenue for Q4 2024 was $17.08M, a 10.74% increase from the previous quarter (Q3 2024), and a 15.40% increase year-over-year (Q4 2023).

What is Ocular Therapeutix’s revenue growth rate?

Ocular Therapeutix's revenue growth rate for the last 3 years (2022-2024) was 23.24%, and for the last 5 years (2020-2024) was 264.66%.

What are Ocular Therapeutix’s revenue streams?

Ocular Therapeutix's revenue streams in c 24 are Product revenue, net, and Collaboration revenue. Product revenue, net generated $63.46M in revenue, accounting 99.59% of the company's total revenue, up 9.66% year-over-year. Collaboration revenue generated $262K in revenue, accounting 0.41% of the company's total revenue, down -54.28% year-over-year.

What is Ocular Therapeutix’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Ocular Therapeutix was Product revenue, net. This segment made a revenue of $63.46M, representing 99.59% of the company's total revenue.